POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced the addition of Janice Bourque,...
3655 promenade Sir William Osler, Montreal, QC, H3G 1Y6, CA/channelsCategory: Public outreach
Medicine and Health Sciences
Dept. of Physiology
Physiology Friday Seminar Series